Clinical trial results show significant weight loss compared to placebo
Si las personas dejan de tomar la medicacin, es probable que muchas necesiten apoyo nutricional y conductual continuo, y los servicios de salud deben anticipar que los beneficios cardiometablicos pueden disminuir a medida que se recupera el peso, dijo Spreckley, agregando que esto resalta la necesidad de ms investigacin sobre estrategias eficaces y escalables para el mantenimiento del peso a largo plazo junto con la farmacoterapia
How GLP-1s Help GLP-1 receptor agonists are a new class of treatments that have piqued interest for treating lipedema
Are B12 complex injections safe for everyone
WADA Prohibited List (2025), Section S2: Peptide Hormones, Growth Factors, Related Substances and Mimetics (Insulin-like Growth Factor-1 and analogues
Nancy Lee: There is this perception in a lot of circles that asking the investee to report more on impact, in particular in the rigorous way that Arsalan was talking about, you know, what's the baseline, what's the change, is a burden
